6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
14m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
14m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
15m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
15m ago	First Quantum Minerals Reports First Quarter 2026 Results
15m ago	District Metals Announces $10 Million Private Placement Financing

About

Vistagen Therapeutics Inc (NASDAQ:VTGN) — investor relations, events, news, and company updates on 6ix.

Latest News

Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause

Vistagen to Participate in Upcoming Investor Conferences

Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference

Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update

Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026

Financials

Revenue

$789 K

Market Cap

$23.24 M

EPS

-1.90

Community Chat

Ask AI